QUICK TO CARE

WIPO WIPO 2019

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke QUICK TO CARE wurde als Wortmarke am 05.06.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 28. April 2023

Markenform Wortmarke
Aktenzeichen 1478954
Länder Europäische Gemeinschaft Japan Mexiko
Basismarke US Nr. 88272876, 23. Januar 2019
Anmeldedatum 05. Juni 2019
Ablaufdatum 05. Juni 2029

Markeninhaber

168 Third Avenue
Waltham MA 02451
US

Markenvertreter

300 Industry Way Pittsburgh PA 15275 US

Waren und Dienstleistungen

35 Business management consultancy for pharmaceutical developers and distributors of investigational medicinal products, comparator medicinal products or placebos used in clinical trials of pharmaceutical products; business management consultancy for pharmaceutical manufacturers and distributors regarding the supply and distribution of pharmaceutical products once such pharmaceutical products have received marketing authorization from us fda or from its non-us counterparts; distribution of samples of pharmaceutical, medical and other preparations, products, samples and supplies used in the conduct of clinical trials of human and veterinary pharmaceutical products; consultancy in the field of supply chain management for pharmaceutical medicines, medicaments, and veterinary products; consulting relating to business strategic planning services in the field of drug substances and drug products; consultancy relating to business plans for investigational medicinal products, comparator medicinal products or placebos used in clinical trials of pharmaceutical products; business management services, namely, consulting relating to managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, supply and demand forecasting and product distribution processes for others, in the field of medicinal products, comparator medicinal products or placebos used in clinical trials of pharmaceutical products
39 Consultancy with respect to the delivery of drug substances and drug products; distribution services, namely, delivery of biopharmaceutical products in connection with the conduct of clinical trials and the delivery of biopharmaceutical products subject to a marketing authorization from US FDA or from its non-US counterparts
40 Consultancy in the field of manufacturing drug products for others
42 Technical management consultancy with respect to the design and development for others of packaging assemblies for investigational medicinal products, comparator medicinal products or placebos used in clinical trials of pharmaceutical products; consultancy with respect to the design and development for others of packaging assemblies for investigational medicinal products, comparator medicinal products or placebos used in clinical trials of pharmaceutical products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
15. März 2023 2023/17 Gaz US RAW: Partial Ceasing Effect
01. April 2021 2021/13 Gaz MX Ablehnung
17. September 2020 2020/38 Gaz JP Ablehnung
07. Januar 2020 2020/2 Gaz EM Ablehnung
05. Juni 2019 2019/28 Gaz US Eintragung

ID: 141478954